Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 5
Original Research
Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,618 | Dovepress* | 5,143+ | 1,007 | 6,150 | |
| PubMed Central* | 475 | 110 | 585 | ||
| Totals | 5,618 | 1,117 | 6,735 | ||
| *Since 12 January 2018 | |||||
View citations on PubMed Central and Google Scholar